I wouldn’t say “effective”. They’re good at rejecting bad things, but they accomplish that largely by being very risk-averse. People who suffer because a treatment wasn’t approved should count for more than they do. The best possible policy might be one that lets a few bad things through if it also lets through a lot more good things.
I wouldn’t say “effective”. They’re good at rejecting bad things, but they accomplish that largely by being very risk-averse. People who suffer because a treatment wasn’t approved should count for more than they do. The best possible policy might be one that lets a few bad things through if it also lets through a lot more good things.
That’s exactly what we would hear everytime we asked about the paperwork from the FDA authorizing human trials. I’m sorry, but it works.